Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Herpes simplex Infection

  Free Subscription

Articles published in Vaccine

Retrieve available abstracts of 10 articles:
HTML format
Text format

Single Articles

    December 2018
  1. HOOK LM, Awasthi S, Dubin J, Flechtner J, et al
    A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infection.
    Vaccine. 2018 Dec 12. pii: S0264-410X(18)31639.
    PubMed     Text format     Abstract available

    November 2018
  2. BERNSTEIN DI, Pullum DA, Cardin RD, Bravo FJ, et al
    The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes.
    Vaccine. 2018 Nov 21. pii: S0264-410X(18)31565.
    PubMed     Text format     Abstract available

    April 2018
  3. ZHANG X, Jiang Q, Xu X, Wang Y, et al
    Immune mechanisms induced by an HSV-1 mutant strain: Discrepancy analysis of the immune system gene profile in comparison with a wild-type strain.
    Vaccine. 2018;36:2394-2402.
    PubMed     Text format     Abstract available

  4. STANFIELD BA, Rider PJF, Caskey J, Del Piero F, et al
    Intramuscular vaccination of guinea pigs with the live-attenuated human herpes simplex vaccine VC2 stimulates a transcriptional profile of vaginal Th17 and regulatory Tr1 responses.
    Vaccine. 2018 Apr 11. pii: S0264-410X(18)30444.
    PubMed     Text format     Abstract available

    December 2017
  5. GOTTLIEB SL, Giersing BK, Hickling J, Jones R, et al
    Meeting report: Initial World Health Organization consultation on herpes simplex virus (HSV) vaccine preferred product characteristics, March 2017.
    Vaccine. 2017 Dec 7. pii: S0264-410X(17)31492.
    PubMed     Text format     Abstract available

    June 2017
  6. GOTTLIEB SL, Giersing B, Boily MC, Chesson H, et al
    Modelling efforts needed to advance herpes simplex virus (HSV) vaccine development: Key findings from the World Health Organization Consultation on HSV Vaccine Impact Modelling.
    Vaccine. 2017 Jun 21. pii: S0264-410X(17)30408.
    PubMed     Text format     Abstract available

  7. ACHDOUT H, Lustig S, Israely T, Erez N, et al
    Induction, treatment and prevention of eczema vaccinatum in atopic dermatitis mouse models.
    Vaccine. 2017 Jun 20. pii: S0264-410X(17)30791.
    PubMed     Text format     Abstract available

    September 2016
  8. FLECHTNER JB, Long D, Larson S, Clemens V, et al
    Immune responses elicited by the GEN-003 candidate HSV-2 therapeutic vaccine in a randomized controlled dose-ranging phase 1/2a trial.
    Vaccine. 2016 Sep 15. pii: S0264-410X(16)30795.
    PubMed     Text format     Abstract available

    March 2016
  9. NICOLI F, Gallerani E, Skarlis C, Sicurella M, et al
    Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection.
    Vaccine. 2016 Mar 18. pii: S0264-410X(16)00333.
    PubMed     Text format     Abstract available

    November 2015
  10. ODEGARD JM, Flynn PA, Campbell DJ, Robbins SH, et al
    A novel HSV-2 subunit vaccine induces GLA-dependent CD4 and CD8 T cell responses and protective immunity in mice and guinea pigs.
    Vaccine. 2015 Nov 10. pii: S0264-410X(15)01600.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Herpes simplex Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.